WIRE โ Transaction Valued at $122.5M Establishes 20,000-Liter US Biologics Drug Substance Manufacturing Platform, Covering Development through Commercial Supply TAIPEI, TAIWAN Media OutReach Newswire 2 July 2026 Bora Pharmaceuticals Co., Ltd. (Bora or Bora Group; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. The post Bora Pharmaceuticals Completes Acquisition of MacroGenics' Rockville Manufacturing Operations appeared first on iHarare News.
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.